Article Information
History
- August 31, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tal Patalon1,2,†,
- Sivan Gazit1,2,†,
- Virginia E. Pitzer3,
- Ottavia Prunas3,
- Joshua L. Warren3,4 and
- Daniel M. Weinberger*,3
- 1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
- 2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Israel
- 3Public Health Modeling Unit, Yale School of Public Health, Yale University; New Haven, CT USA
- 4Department of Biostatistics, Yale School of Public Health, Yale University; New Haven, CT USA
- ↵*Corresponding author: Daniel M. Weinberger, daniel.weinberger{at}yale.edu, Yale School of Public Health, Yale University, New Haven, CT USA
↵† These authors contributed equally to this work.
Posted August 31, 2021.
Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine
